• Home
  • NEW DAY MEDICINE
  • 9 (71) 2024
  • 21 -9 (71) 2024 - Kholov U.A. Ergashov M.M. - PREDICTIVE VALUES OF PROCALCITONIN FOR SECONDARY BACTERIAL INFECTIONS IN PATIENTS WITH COVID-19

21 -9 (71) 2024 - Kholov U.A. Ergashov M.M. - PREDICTIVE VALUES OF PROCALCITONIN FOR SECONDARY BACTERIAL INFECTIONS IN PATIENTS WITH COVID-19

PREDICTIVE VALUES OF PROCALCITONIN FOR SECONDARY BACTERIAL INFECTIONS IN PATIENTS WITH COVID-19

Kholov U.A. - Bukhara Regional Hospital of Infectious Diseases

Ergashov M.M. - Bukhara State Medical Institute named after Abu Ali ibn Sino

Resume

This article highlights the importance of C-reactive protein (CRP) and procalcitonin (PCT), and cytokines in determining the prognosis of SARS-CoV-2-associated pneumonia. The article discusses the methods used to measure these biomarkers and the results of studies that have investigated their use in predicting the severity and outcome of SARS-CoV-2-associated pneumonia.

Keywords: SARS-CoV-2, pneumonia, C-reactive protein, procalcitonin, cytokines, biomarkers, prognosis.

First page

108

Last page

111

For citation:Kholov U.A. Ergashov M.M. - PREDICTIVE VALUES OF PROCALCITONIN FOR SECONDARY BACTERIAL INFECTIONS IN PATIENTS WITH COVID-19//New Day in Medicine 9(71)2024 108-111 https://newdayworldmedicine.com/en/new_day_medicine/9-71-2024

List of References

  1. Arsenault, C., Gage, A., Kim, M.K. et al. COVID-19 and resilience of healthcare systems in ten countries. //Nat Med 2022;28:131-1324.
  2. Oblokulov A.R., Husenova Z. Z., Ergashev M. M. (2021). Procalcitonin as an indicator of antibacterial therapy in covid-19. //Annals of the Romanian Society for Cell Biology 2021; 5220-5224.
  3. Scaglioni V., Soriano E.R. Are super antigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis //Scand. J. Immunology 2020;92(6):1-5.
  4. Oblokulov A.R., Niyozov G.E. (2020) Clinical and epidemiological characteristics of patients with COVID-19. //International Journal of Pharmaceutical Research; 2020;12(4):3749-3752.
  5. Gorbalenya A.E., et al. The species Severe acute res piratory syndrome-related corona-virus: classifying 2019-nCoV and naming it SARS-CoV-2 //Nat. Microbiol. 2020;5(4):536-544.
  6. Encyclopaedia Britannica, Inc. – URL: https://www.britannica.com (date of viewing: 12.01.2021).
  7. Mahendra M, Nuchin A, Kumar R, et al. (2021) Predictors of mortality in patients with severe COVID-19 pneumonia—a retrospective study. //Adv Respir Med 2021;89:135-144.
  8. Bosch B.J., et al. The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex //J. Virol. 2003;77(16):8801-8811.
  9. Lanzavecchia A. Antigen-specific interaction between T and B cells //Nature. 1985;314(11):537-539.
  10. Scaglioni V., Soriano E.R. Are superantigens the cause of cytokine storm and viral sepsis in severe COVID-19? Observations and hypothesis //Scand. J. Immunol. 2020;92(6):1-5.
  11. Gorbalenya A.E., et al. The species Severe acute res piratory syndrome-related corona-virus: classifying 2019-nCoV and naming it SARS-CoV-2 //Nat. Microbiol. 2020;5(4):536-544.
  12. Encyclopaedia Britannica, Inc. – URL: https:// www.britannica.com (date of viewing: 12.01.2021).
  13. Schoeman, D. Coronavirus envelope protein: current knowledge //Virol. J. 2019;16(1):69.
  14. Williams E.J. et al. (2020). Routine measurement of serum procalcitonin allows antibiotics to be safely with held in patients admitted to hospital with SARS-CoV-2 infection. medRxiv. doi. org/10.1101/2020.06.29.20136572.
  15. Oblokulov A.R., Kholov U.A., Niyozov G.E., Khusenova Z.Z., Ergashov M.M. (2021) Extrapulmonal manifestations of COVID – 19 //“Infection, immunity and pharmacology –scientific and practical journal 2021;1:62-66.
  16. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: con-sider cytokine storm syndromes and immunosuppression. //Lancet. 2020;395:1033–1034. doi: 10.1016/S0140-6736(20)30628-0.
  17. Облокулов А.Р., Хусенова З.З., Эргашов М.М. (2021) Значение Уровня Прокальцитонина при назначении и мониторинга антибактериальной терапии пациентов с COVID – 19 //Журнал гепато – гастроэнтерологических исследований. 2021;1(СВ):115-117.
  18. Nahum J, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19) //JAMA Netw. Open. 2020;3:e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
  19. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. //J. Thromb. Haemost. 2020;18:1421–1424. doi: 10.1111/jth.14830.
  20. Zhou F, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. //Lancet. 2020; 395:1054–1062. doi: 10.1016/S0140-6736(20)30566-3.

    file

    download